Publications

The journal of pathology. Clinical research

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

01-01-2015

Human molecular genetics

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

15-11-2014

Human molecular genetics

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

15-11-2014

PloS one

MicroRNA related polymorphisms and breast cancer risk.

13-11-2014

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

[Not Available].

01-11-2014

Nature communications

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

23-09-2014

Breast cancer research : BCR

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

26-05-2014

The Journal of pathology

Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.

01-07-2013

Breast cancer research and treatment

Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.

01-11-2011

Human molecular genetics

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

15-08-2011

Nature genetics

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).

01-12-2010

International journal of radiation oncology, biology, physics

Radiation-associated breast tumors display a distinct gene expression profile.

01-02-2010

Breast cancer research : BCR

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.

22-12-2009

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

10-09-2009

Hereditary cancer in clinical practice

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype.

17-02-2009

Breast cancer research and treatment

The spectrum of ATM missense variants and their contribution to contralateral breast cancer.

01-01-2008

Cancer research

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.

01-10-2007

Blood

In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma.

15-08-2007

Breast cancer research : BCR

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

13-04-2007

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.

01-01-2007

Breast cancer research and treatment

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers.

01-01-2004

Journal of the National Cancer Institute

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

02-07-2003

Human mutation

IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.

01-05-2003

Nederlands tijdschrift voor geneeskunde

[From gene to disease; ataxia telangiectasia].

01-03-2003

International journal of radiation biology

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

01-05-2000

American journal of human genetics

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

01-02-2000

Human mutation

ATM germline mutations in classical ataxia-telangiectasia patients in the Dutch population.

29-10-1998

The EMBO journal

Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans.

15-11-1996

The EMBO journal

A P-glycoprotein protects Caenorhabditis elegans against natural toxins.

01-05-1995

Proceedings of the National Academy of Sciences of the United States of America

Target-selected gene inactivation in Caenorhabditis elegans by using a frozen transposon insertion mutant bank.

15-08-1993